{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:39:41Z","timestamp":1772163581000,"version":"3.50.1"},"reference-count":66,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Grant #: CKS-174105"],"award-info":[{"award-number":["Grant #: CKS-174105"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,10,22]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The four SARS-CoV-2 variants of concern (VOC; Alpha, Beta, Gamma and Delta) identified by May 2021 are highly transmissible, yet little is known about their impact on public health measures. We aimed to synthesise evidence related to public health measures and VOC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A rapid scoping review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>On 11 May 2021, seven databases (MEDLINE, Embase, the Cochrane Database of Systematic Reviews, Central Register of Controlled Trials, Epistemonikos\u2019 L-OVE on COVID-19, medRxiv, bioRxiv) were searched for terms related to VOC, public health measures, transmission and health systems. No limit was placed on date of publication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Studies were included if they reported on any of the four VOCs and public health measures, and were available in English. Only studies reporting on data collected after October 2020, when the first VOC was reported, were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Titles, abstracts and full-text articles were screened by two independent reviewers. Data extraction was completed by two independent reviewers using a standardised form. Data synthesis and reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 37 included studies, the majority assessed the impact of Alpha (n=32) and were conducted in Europe (n=12) or the UK (n=9). Most were modelling studies (n=28) and preprints (n=28). The majority of studies reported on infection control measures (n=17), followed by modifying approaches to vaccines (n=13), physical distancing (n=6) and either mask wearing, testing or hand washing (n=2). Findings suggest an accelerated vaccine rollout is needed to mitigate the spread of VOC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The increased severity of VOC requires proactive public health measures to control their spread. Further research is needed to strengthen the evidence for continued implementation of public health measures in conjunction with vaccine rollout. With no studies reporting on Delta, there is a need for further research on this and other emerging VOC on public health measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-055781","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:27:20Z","timestamp":1638448040000},"page":"e055781","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4699-7278","authenticated-orcid":false,"given":"Mari","family":"Somerville","sequence":"first","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Pediatrics, IWK Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-0467","authenticated-orcid":false,"given":"Janet A","family":"Curran","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Pediatrics, IWK Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Dol","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Boulos","sequence":"additional","affiliation":[{"name":"Maritime SPOR SUPPORT Unit, Nova Scotia Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynora","family":"Saxinger","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Doroshenko","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Hastings","sequence":"additional","affiliation":[{"name":"Health Systems Evaluation and Evidence, Alberta Health Services, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bearach","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St Vincents Hospital, Dublin, Leinster, UK"},{"name":"Evidence Synthesis Ireland, National University of Ireland, Galway, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2933-7470","authenticated-orcid":false,"given":"Allyson J","family":"Gallant","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwayeon Danielle","family":"Shin","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Wong","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-8189","authenticated-orcid":false,"given":"Daniel","family":"Crowther","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Martin-Misener","sequence":"additional","affiliation":[{"name":"Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Comeau","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Division of Infectious Diseases, IWK Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-5531","authenticated-orcid":false,"given":"Holly","family":"McCulloch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, IWK Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-8971","authenticated-orcid":false,"given":"Andrea C","family":"Tricco","sequence":"additional","affiliation":[{"name":"Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada"},{"name":"Epidemiology Division and Institute for Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Queen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, School of Nursing, Queen's University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"2025121410265777000_11.12.e055781.1","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i1.9397"},{"key":"2025121410265777000_11.12.e055781.2","unstructured":"WHO . Weekly operational update on COVID-19 - 24 May 2021, 2021. Available: https:\/\/www.who.int\/publications\/m\/item\/weekly-operational-update-on-covid-19-24-may-2021 [Accessed 28 May 2021]."},{"key":"2025121410265777000_11.12.e055781.3","unstructured":"WHO . SARS-CoV-2 variants. World Health Organization, 2020. http:\/\/www.who.int\/csr\/don\/31-december-2020-sars-cov2-variants\/en\/"},{"key":"2025121410265777000_11.12.e055781.4","unstructured":"WHO . COVID-19 Weekly epidemiological update - February 25, 2021, 2021. Available: https:\/\/www.who.int\/publications\/m\/item\/covid-19-weekly-epidemiological-update [Accessed 12 Mar 2021]."},{"key":"2025121410265777000_11.12.e055781.5","unstructured":"WHO . Weekly epidemiological update on COVID-19 - 25 May 2021. Available: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19-25-may-2021 [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.6","unstructured":"Public Health England . Investigation of novel SARS-COV-2 variant: variant of concern 202012\/01, 2020. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/959438\/Technical_Briefing_VOC_SH_NJL2_SH2.pdf [Accessed 09 Mar 2021]."},{"key":"2025121410265777000_11.12.e055781.7","doi-asserted-by":"crossref","unstructured":"Curran JA , Dol J , Boulos L . Transmission characteristics of SARS-CoV-2 variants of concern: rapid scoping review. medRxiv 2021;21255515. [Epub ahead of print: 2021.04.23].doi:10.1101\/2021.04.23.21255515","DOI":"10.1101\/2021.05.20.21257517"},{"key":"2025121410265777000_11.12.e055781.8","doi-asserted-by":"crossref","unstructured":"Wibmer CK , Ayres F , Hermanus T . SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. bioRxiv 2021.doi:10.1038\/s41591-021-01285-x","DOI":"10.1101\/2021.01.18.427166"},{"key":"2025121410265777000_11.12.e055781.9","unstructured":"Agency for Clinical Innovation . Living Evidence - SARS-CoV-2 variants, 2021. Available: https:\/\/aci.health.nsw.gov.au\/covid-19\/critical-intelligence-unit\/sars-cov-2-variants [Accessed 24 Apr 2021]."},{"key":"2025121410265777000_11.12.e055781.10","unstructured":"WHO . Strategic planning and operational guidance for maintaining essential health services during an outbreak. Available: https:\/\/www.who.int\/publications-detail-redirect\/strategic-planning-and-operational-guidance-for-maintaining-essential-health-services-during-an-outbreak [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.11","unstructured":"WHO . Listings of WHO\u2019s response to COVID-19. Available: https:\/\/www.who.int\/news\/item\/29-06-2020-covidtimeline [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.12","unstructured":"WHO . Advice on the use of masks in the context of COVID-19: interim guidance, 5 June 2020, 2020. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/332293 [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.13","unstructured":"WHO . Laboratory testing strategy recommendations for COVID-19: interim guidance. Available: https:\/\/www.who.int\/publications-detail-redirect\/laboratory-testing-strategy-recommendations-for-covid-19-interim-guidance [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.14","unstructured":"WHO . Considerations for implementing and adjusting public health and social measures in the context of COVID-19. Available: https:\/\/www.who.int\/publications-detail-redirect\/considerations-in-adjusting-public-health-and-social-measures-in-the-context-of-covid-19-interim-guidance [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30746-7"},{"key":"2025121410265777000_11.12.e055781.16","unstructured":"Tricco AC , Langlois EV , Straus SE . Rapid reviews to strengthen health policy and systems: a practical guide, 2017. Available: http:\/\/apps.who.int\/iris\/bitstream\/10665\/258698\/1\/9789241512763-eng.pdf [Accessed 09 Mar 2021]."},{"key":"2025121410265777000_11.12.e055781.17","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000050"},{"key":"2025121410265777000_11.12.e055781.18","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-1-10"},{"key":"2025121410265777000_11.12.e055781.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"2025121410265777000_11.12.e055781.20","unstructured":"Covidence . Covidence - Better systematic review management. Available: https:\/\/www.covidence.org\/ [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.21","unstructured":"Wells G , Shea B , O\u2019Connell D . The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Ottawa Hospital Research Institute. Available: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [Accessed 23 Apr 2021]."},{"key":"2025121410265777000_11.12.e055781.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147601"},{"key":"2025121410265777000_11.12.e055781.23","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2025121410265777000_11.12.e055781.24","doi-asserted-by":"crossref","unstructured":"Abdel Sater F , Younes M , Nassar H . A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR green-based RT-qPCR. medRxiv 2021;21250048.","DOI":"10.1101\/2021.01.27.21250048"},{"key":"2025121410265777000_11.12.e055781.25","doi-asserted-by":"crossref","unstructured":"Ahn H-S , Silberholz J , Song X . Optimal COVID-19 containment strategies: evidence across multiple mathematical models. Rochester, NY: Social Science Research Network, 2021. https:\/\/papers.ssrn.com\/abstract=3834668","DOI":"10.2139\/ssrn.3834668"},{"key":"2025121410265777000_11.12.e055781.26","doi-asserted-by":"crossref","unstructured":"Aiano F , McOwat K , Obi C . COVID-19 outbreaks in nurseries during rapid spread of the B.1.1.7 variant of SARS-CoV-2 in England: cross-sectional national surveillance, November 2020 \u2013 January 2021. Rochester, NY: Social Science Research Network, 2021.","DOI":"10.2139\/ssrn.3826200"},{"key":"2025121410265777000_11.12.e055781.27","doi-asserted-by":"crossref","unstructured":"Akingba OL , Sprong K , Hardie DR . Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the eastern cape, South Africa. medRxiv 2021;21251057.","DOI":"10.1101\/2021.02.03.21251057"},{"key":"2025121410265777000_11.12.e055781.28","doi-asserted-by":"crossref","unstructured":"Bachtiger P , Adamson A , Maclean WA . Increasing but inadequate intention to receive Covid-19 vaccination over the first 50 days of impact of the more infectious variant and roll-out of vaccination in UK: indicators for public health messaging. medRxiv 2021;21250083.","DOI":"10.1101\/2021.01.30.21250083"},{"key":"2025121410265777000_11.12.e055781.29","doi-asserted-by":"crossref","unstructured":"Borges V , Sousa C , Menezes L , et al . Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021. Euro Surveill 2021;26 https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2021.26.10.2100130 doi:10.2807\/1560-7917.ES.2021.26.10.2100130","DOI":"10.2807\/1560-7917.ES.2021.26.10.2100130"},{"key":"2025121410265777000_11.12.e055781.30","unstructured":"Bosetti P , Kiem CT , Andronico A . A race between SARS-CoV-2 variants and vaccination: the case of the B.1.1.7 variant in France, 2021. Available: https:\/\/hal-pasteur.archives-ouvertes.fr\/pasteur-03149525 [Accessed 26 May 2021]."},{"key":"2025121410265777000_11.12.e055781.31","article-title":"Increased household secondary attacks rates with variant of concern SARS-CoV-2 index cases","volume":"21254502","author":"Buchan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025121410265777000_11.12.e055781.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.04.029"},{"key":"2025121410265777000_11.12.e055781.33","doi-asserted-by":"crossref","unstructured":"Collier DA , IATM F , Datir R . Age-related heterogeneity in immune responses to SARS-CoV-2 vaccine BNT162b2. medRxiv 2021;21251054. [Epub ahead of print: 2021.02.03].doi:10.1101\/2021.02.03.21251054","DOI":"10.1101\/2021.02.03.21251054"},{"key":"2025121410265777000_11.12.e055781.34","doi-asserted-by":"crossref","unstructured":"Domenico LD , Sabbatini CE , Pullano G . Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France. medRxiv 2021;21251708. [Epub ahead of print: 2021.02.14].doi:10.1101\/2021.02.14.21251708","DOI":"10.1101\/2021.02.14.21251708"},{"key":"2025121410265777000_11.12.e055781.35","doi-asserted-by":"crossref","unstructured":"Giordano G , Colaneri M , Di Filippo A . Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy. Nature Medicine 2021:1\u20136.doi:10.1038\/s41591-021-01334-5","DOI":"10.1038\/s41591-021-01334-5"},{"key":"2025121410265777000_11.12.e055781.36","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1016\/S2468-2667(21)00055-4","article-title":"Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study","volume":"6","author":"Graham","year":"2021","journal-title":"Lancet Public Health"},{"key":"2025121410265777000_11.12.e055781.37","doi-asserted-by":"crossref","unstructured":"Gurbaxani BM , Hill AN , Paul P . Evaluation of different types of face masks to limit the spread of SARS-CoV-2 \u2013 a modeling study. medRxiv 2021;21255889. [Epub ahead of print: 2021.04.21].doi:10.1101\/2021.04.21.21255889","DOI":"10.1101\/2021.04.21.21255889"},{"key":"2025121410265777000_11.12.e055781.38","doi-asserted-by":"crossref","unstructured":"Kim D , Keskinocak P , Pekg\u00fcn P . The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants. medRxiv 2021;21255217. [Epub ahead of print: 2021.04.09].doi:10.1101\/2021.04.09.21255217","DOI":"10.1101\/2021.04.09.21255217"},{"key":"2025121410265777000_11.12.e055781.39","unstructured":"K\u00fchn MJ , Abele D , Binder S . Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants. medRxiv 2021;21255995. doi:doi:10.1101\/2021.04.23.21255995. [Epub ahead of print: 2021.04.23] https:\/\/www.medrxiv.org\/content\/10.1101\/2021.04.23.21255995v1.full"},{"key":"2025121410265777000_11.12.e055781.40","doi-asserted-by":"crossref","unstructured":"Lasser J , Sorger J , Richter L . Assessing the impact of SARS-CoV-2 prevention measures in schools by means of agent-based simulations calibrated to cluster tracing data. medRxiv 2021;21255320. [Epub ahead of print: 2021.04.13].doi:10.1101\/2021.04.13.21255320","DOI":"10.1101\/2021.04.13.21255320"},{"key":"2025121410265777000_11.12.e055781.41","doi-asserted-by":"crossref","unstructured":"Linka K , Peirlinck M , Sch\u00e4fer A . Effects of B.1.1.7 and B.1.351 on COVID-19 dynamics. A campus reopening study. medRxiv 2021;21255954. [Epub ahead of print: 2021.04.22].doi:10.1101\/2021.04.22.21255954","DOI":"10.1101\/2021.04.22.21255954"},{"key":"2025121410265777000_11.12.e055781.42","doi-asserted-by":"crossref","unstructured":"Lumley SF , Rodger G , Constantinides B . An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status. medRxiv 2021;21253218.doi:10.1101\/2021.03.09.21253218","DOI":"10.1101\/2021.03.09.21253218"},{"key":"2025121410265777000_11.12.e055781.43","doi-asserted-by":"crossref","unstructured":"Luo G , Hu Z , Letterio JJ . Modeling and predicting antibody durability for mRNA-1273 vaccine for SARS-CoV-2 variants. medRxiv 2021;21256537. [Epub ahead of print: 2021.05.04].doi:10.1101\/2021.05.04.21256537","DOI":"10.1101\/2021.05.04.21256537"},{"key":"2025121410265777000_11.12.e055781.44","doi-asserted-by":"crossref","unstructured":"Meister T , Fortmann J , Todt D . Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1. J Infect Dis 2021;351 https:\/\/academic.oup.com\/jid\/article\/224\/3\/420\/6276396 doi:","DOI":"10.1093\/infdis\/jiab260"},{"key":"2025121410265777000_11.12.e055781.45","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00143-2\/ATTACHMENT\/6721682C-734C-4335-A43B-6F5B618390E1\/MMC1.PDF"},{"key":"2025121410265777000_11.12.e055781.46","doi-asserted-by":"crossref","first-page":"100264","DOI":"10.1016\/j.xcrm.2021.100264","article-title":"BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel","volume":"2","author":"Munitz","year":"2021","journal-title":"Cell Rep Med"},{"key":"2025121410265777000_11.12.e055781.47","doi-asserted-by":"crossref","unstructured":"Pageaud S , Ponthus N , Gauchon R . Adapting French COVID-19 vaccination campaign duration to variant dissemination. medRxiv 2021;21253739.","DOI":"10.1101\/2021.03.17.21253739"},{"key":"2025121410265777000_11.12.e055781.48","doi-asserted-by":"crossref","first-page":"100865","DOI":"10.1016\/j.eclinm.2021.100865","article-title":"Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants","volume":"35","author":"Sah","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2025121410265777000_11.12.e055781.49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s41885-021-00083-6","article-title":"Assessing the optimality of a COVID Lockdown in the United States","volume":"5","author":"Scherbina","year":"2021","journal-title":"Econ Disaster Clim Chang"},{"key":"2025121410265777000_11.12.e055781.50","doi-asserted-by":"crossref","unstructured":"Smith TP , Dorigatti I , Mishra S . Environmental drivers of SARS-CoV-2 lineage B.1.1.7 transmission intensity. medRxiv 2021;21253242. doi:doi:10.1101\/2021.03.09.21253242. [Epub ahead of print: 2021.03.09] https:\/\/www.medrxiv.org\/content\/10.1101\/2021.03.09.21253242v2","DOI":"10.1101\/2021.03.09.21253242"},{"key":"2025121410265777000_11.12.e055781.51","doi-asserted-by":"crossref","unstructured":"Teslya A , Rozhnova G , Pham T . The importance of sustained compliance with physical distancing during COVID-19 vaccination rollout. Research Square.doi:10.21203\/rs.3.rs-390037\/v2","DOI":"10.21203\/rs.3.rs-390037\/v2"},{"key":"2025121410265777000_11.12.e055781.52","doi-asserted-by":"crossref","unstructured":"Tokuda Y , Kuniya T . Japan\u2019s Covid mitigation strategy and its epidemic prediction. medRxiv 2021;21256476.doi:10.1101\/2021.05.06.21256476","DOI":"10.1101\/2021.05.06.21256476"},{"key":"2025121410265777000_11.12.e055781.53","doi-asserted-by":"crossref","unstructured":"Vazquez A , Staebler M , Khanin A . Estimating the super-spreading rate at workplaces using bluetooth technology. medRxiv 2021;21252550.doi:10.1101\/2021.03.04.21252550","DOI":"10.1101\/2021.03.04.21252550"},{"key":"2025121410265777000_11.12.e055781.54","doi-asserted-by":"crossref","unstructured":"Wells CR , Townsend JP , Pandey A . Quarantine and testing strategies for safe pandemic travel. Epidemiology 2021.doi:10.1101\/2021.04.25.21256082","DOI":"10.1101\/2021.04.25.21256082"},{"key":"2025121410265777000_11.12.e055781.55","unstructured":"Shattock AJ , Rutte EAL , D\u00fcnner RP . Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland. medRxiv 2021;21255503. doi:doi:10.1101\/2021.04.14.21255503. [Epub ahead of print: 2021.04.14] https:\/\/www.medrxiv.org\/content\/10.1101\/2021.04.14.21255503v1"},{"key":"2025121410265777000_11.12.e055781.56","doi-asserted-by":"crossref","unstructured":"Piantham C , Ito K . Estimating the increased transmissibility of the B.1.1.7 strain over previously circulating strains in England using frequencies of GISAID sequences and the distribution of serial intervals. medRxiv 2021;21253775 https:\/\/www.medrxiv.org\/content\/10.1101\/2021.03.17.21253775v4 doi:10.1101\/2021.03.17.21253775","DOI":"10.1101\/2021.03.17.21253775"},{"key":"2025121410265777000_11.12.e055781.57","doi-asserted-by":"crossref","unstructured":"Jangra S , Ye C , Rathnasinghe R . The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. medRxiv 2021;21250543. [Epub ahead of print: 2021.01.26].doi:10.1101\/2021.01.26.21250543","DOI":"10.1101\/2021.01.26.21250543"},{"key":"2025121410265777000_11.12.e055781.58","doi-asserted-by":"crossref","unstructured":"Victora C , Castro MC , Gurzenda S . Estimating the early impact of immunization against COVID-19 on deaths among elderly people in Brazil: analyses of secondary data on vaccine coverage and mortality. medRxiv 2021;21256187. [Epub ahead of print: 2021.04.27].doi:10.1101\/2021.04.27.21256187","DOI":"10.1016\/j.eclinm.2021.101036"},{"key":"2025121410265777000_11.12.e055781.59","doi-asserted-by":"crossref","unstructured":"Yang HM , Junior LPL , Castro FFM . Quarantine, relaxation and mutation explaining the CoViD-19 epidemic in S\u00e3o Paulo state (Brazil). medRxiv 2021;21255325. [Epub ahead of print: 2021.04.12].doi:10.1101\/2021.04.12.21255325","DOI":"10.1101\/2021.04.12.21255325"},{"key":"2025121410265777000_11.12.e055781.60","article-title":"Stay-at-home orders are associated with emergence of novel SARS-CoV-2 variants","volume":"13","author":"Zimerman","year":"2021","journal-title":"Cureus"},{"key":"2025121410265777000_11.12.e055781.61","doi-asserted-by":"crossref","unstructured":"Oliver SE . The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine \u2014 United States, December 2020. MMWR Morb Mortal Wkly Rep 2020:69.doi:10.15585\/mmwr.mm6950e2","DOI":"10.15585\/mmwr.mm6950e2"},{"key":"2025121410265777000_11.12.e055781.62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4714"},{"key":"2025121410265777000_11.12.e055781.63","doi-asserted-by":"crossref","DOI":"10.1186\/s13584-021-00453-1","article-title":"Who should be vaccinated first? comparing vaccine prioritization strategies in Israel and European countries using the Covid-19 health system response monitor","volume":"10","author":"Cylus","year":"2021","journal-title":"Isr J Health Policy Res"},{"key":"2025121410265777000_11.12.e055781.64","unstructured":"WHO . Who SAGE roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply. Available: https:\/\/www.who.int\/publications-detail-redirect\/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply [Accessed 15 Jun 2021]."},{"key":"2025121410265777000_11.12.e055781.65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14745\/ccdr.v45i01a02","article-title":"Effectiveness of hand hygiene practices in preventing influenza virus infection in the community setting: a systematic review","volume":"45","author":"Moncion","year":"2019","journal-title":"Can Commun Dis Rep"},{"key":"2025121410265777000_11.12.e055781.66","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-055781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:27:10Z","timestamp":1765736830000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-055781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":66,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,2]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bmjopen-2021-055781"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-055781","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.20.21257517","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}